Chris Cotsapas

Chris Cotsapas currently holds the role of Senior Vice President of Platform Development at Vesalius Therapeutics. Alongside this position, Cotsapas is a Research Affiliate at the Broad Institute of MIT and Harvard. Previously, Cotsapas has worked at various prestigious institutions such as Yale University School of Medicine, Harvard Medical School, and Massachusetts General Hospital, holding titles such as Professor of Neurology and Genetics, Research Fellow, and Associate/Assistant Professor. Cotsapas obtained a PhD in Biochemistry and Molecular Genetics from UNSW and a B.Sc. in Biochemistry from Imperial College London.